Results 1 to 10 of about 85 (70)
Mucus hypersecretion is a clinical feature of severe respiratory diseases such as asthma, cystic fibrosis and chronic obstructive pulmonary disease.
R. Balsamo, L. Lanata, C. G. Egan
doaj +2 more sources
Pharmacological approaches to the rational choice of combined mucoactive drugs
The article analyzes the literature data and considers modern drugs of mucoactive therapy used for cough. The points of application and mechanism of action of the main groups of mucoactive drugs – expectorants, mucokinetics, mucoregulators and mucolytics
S. V. Okovity +3 more
doaj +1 more source
Pharmacodynamic approaches to the use of mucoactive drugs
Cough is a reflex, protective and adaptive reaction of the body aimed at removing foreign sub-stances and/or pathologically altered tracheobronchial secretions from the respiratory tract.
S. V. Okovity +2 more
doaj +1 more source
Approaches to the diagnosis and therapy of cough in therapeutic practice
Cough is one of the most important symptoms of the pathology of various organs and systems, which occurs in about 30% of the human population. This symptom prevails in patients with various bronchopulmonary pathologies, however, in addition, it can occur
D. S. Sukhanov +2 more
doaj +1 more source
Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery [PDF]
In a number of pulmonary diseases, patients may develop abnormally viscous mucus reducing drug efficacy. To increase budesonide diffusion within lung fluid, we developed nanoporous microparticles (NPMPs) composed of budesonide and a mucokinetic, ambroxol hydrochloride, to be inhaled as a dry powder.
Tewes, Frederic +6 more
openaire +5 more sources
Effects of Mucokinetic Drugs on Rheological Properties of Reconstituted Human Nasal Mucus [PDF]
To investigate the effects of mucokinetic drugs on the rheological properties of human nasal mucus in patients with chronic sinusitis.We reconstituted human nasal mucus obtained from 74 patients with chronic sinusitis and determined the effects of 4 mucokinetic drugs, including acetylcysteine, deoxynuclease I, 2% sodium bicarbonate, and a combination ...
C S, Rhee +5 more
openaire +2 more sources
Place of combination drugs in the therapy of acute bronchitis in children
Acute respiratory tract infections accompanied by cough play a significant role in respiratory pathology in childhood. The incidence of acute respiratory infections among children is 4–5 times higher than among the adult population and accounts for more ...
N. G. Kolosova +3 more
doaj +1 more source
Tropical Food Spices: A Promising Panacea for the Novel Coronavirus Disease (COVID‐19)
GRAPHICAL ABSTRACT Coronavirus disease 2019 (COVID‐19) is an infectious fatal disease caused by the Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) with millions of individuals infected globally within few months of its outbreak. During infection, the SARS‐CoV‐2 main protease binds directly to Angiotensin‐converting Enzyme 2 (ACE2 ...
Adedayo O. Ademiluyi +2 more
wiley +1 more source
Intracerebral hemorrhage (ICH) has been becoming a serious public health problem. Pneumonia, occurring in 43% of all ICH patients, is a common complication heavily influencing outcome and accounting for more than 1/3 of the overall mortality in patients with ICH. Ambroxol may be an effective additional treatment for ICH patients with pneumonia. But its
Xuheng Jiang +12 more
wiley +1 more source
PEDIATRICIAN’S APPROACH TO THE CHOICE OF MEDICATION AGAINST COUGH IN CHILDREN
Cough is a common symptom in respiratory pathology which is associated with 30% of all visits to therapist and more than 50% to pediatrician, especially during the period of respiratory infection outbreak.
I. N. Zakharova, I. V. Berezhnaya
doaj +1 more source

